Publications by authors named "F Afzal"

Background: Fulminant myocarditis (FM) is a potentially life-threatening disease that requires emergency care. The authors' study aims to explore clinical outcomes and predictors of survival when using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for the treatment of FM in adult and pediatric patients to analyze differences between both populations.

Methods: PubMed, Scopus, Web of Science, and Cochrane databases were searched for studies reporting the effect of VA-ECMO on patients diagnosed with fulminant myocarditis.

View Article and Find Full Text PDF

Since non-thermal atmospheric-pressure ("cold") plasma sources, such as the dielectric-barrier discharge (DBD), have appeared to be remarkably active in wound healing medicine, the elucidation of cold plasma safety and possible secondary undesirable effects becomes of paramount importance. Selenium-containing amino acids, which are commonly incorporated in many enzymes, came in the spotlight for elucidating the plasma impact as easily oxidizable natural targets. The scope of this study was to analyse the impact of non-thermal plasma on selenium-containing amino acids.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers have designed and successfully created a slotted photonic crystal with features as small as 40 nm using a standard silicon photonics process.
  • The unique design increases the electric field energy by four times compared to traditional slotted photonic crystals by using a specialized unit cell shape that enhances optical energy localization.
  • This work paves the way for future development of advanced photonic structures that could improve applications like biosensing and light manipulation on-chip.
View Article and Find Full Text PDF

There exists a potential interdependence among the United States markets, alongside an exceptional dependence on the East Asian stock markets. This transmission of risks is similarly evident in funds that are traded within markets. The current study seeks to uncover the pathways of risk contagion among various financial markets.

View Article and Find Full Text PDF
Article Synopsis
  • - Ruxolitinib, a JAK1/JAK2 inhibitor, shows improved effectiveness in managing polycythemia vera (PV) compared to best available therapy (BAT), with higher rates of hematocrit control and treatment response, especially in patients resistant to hydroxyurea.
  • - The analysis of six studies with over 1,000 patients found that ruxolitinib also significantly improved symptoms related to myeloproliferative neoplasms.
  • - While ruxolitinib reduces thromboembolism risk, it is linked to increased rates of anemia, herpes zoster infections, and nonmelanoma skin cancer.
View Article and Find Full Text PDF